留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

良性肝脏肿瘤肝移植相关进展

倪远之, 张武. 良性肝脏肿瘤肝移植相关进展[J]. 器官移植, 2022, 13(6): 742-748. doi: 10.3969/j.issn.1674-7445.2022.06.008
引用本文: 倪远之, 张武. 良性肝脏肿瘤肝移植相关进展[J]. 器官移植, 2022, 13(6): 742-748. doi: 10.3969/j.issn.1674-7445.2022.06.008
Ni Yuanzhi, Zhang Wu. Research progress on liver transplantation for benign liver tumors[J]. ORGAN TRANSPLANTATION, 2022, 13(6): 742-748. doi: 10.3969/j.issn.1674-7445.2022.06.008
Citation: Ni Yuanzhi, Zhang Wu. Research progress on liver transplantation for benign liver tumors[J]. ORGAN TRANSPLANTATION, 2022, 13(6): 742-748. doi: 10.3969/j.issn.1674-7445.2022.06.008

良性肝脏肿瘤肝移植相关进展

doi: 10.3969/j.issn.1674-7445.2022.06.008
基金项目: 

国家科技重大专项 2018ZX10301201

济南微生态生物医学省实验室科研项目资助重点项目 JNL-2022015B

详细信息
    作者简介:
    通讯作者:

    张武,Email:wu.zhang@shulan.com

  • 中图分类号: R617, R735.7

Research progress on liver transplantation for benign liver tumors

More Information
  • 摘要: 肝脏肿瘤分为良性和恶性,其中良性肝脏肿瘤较为常见,治疗以随访观察、介入治疗为主,仅少数情况下需要进行外科手术切除治疗。肝移植可有效治疗终末期肝病,但通常不作为良性肝脏肿瘤的治疗手段,仅存在巨大占位压迫、合并肝衰竭、肿瘤破裂出血风险或恶变风险的良性肝脏肿瘤才考虑进行肝移植治疗。与恶性肿瘤及慢性肝衰竭肝移植相比,良性肝脏肿瘤肝移植手术风险相当,预后及远期生存较为理想。但良性肝脏肿瘤肝移植术前应充分谨慎评估,同时注意新形势下供肝匹配难度。本文对良性肝脏肿瘤包括肝血管瘤、多囊肝、肝细胞腺瘤、肝脏间叶错构瘤等肝移植相关研究进展进行总结,旨在为肝移植治疗良性肝脏肿瘤提供参考。

     

  • [1] AEHLING NF, SEEHOFER D, BERG T. Liver transplantation-current trends[J]. Dtsch Med Wochenschr, 2020, 145(16): 1124-1131. DOI: 10.1055/a-0982-0737.
    [2] 国际肝胆胰协会中国分会肝血管瘤专业委员会. 肝血管瘤诊断和治疗多学科专家共识(2019版)[J]. 中华消化外科杂志, 2019, 18(8): 705-710. DOI: 10.3760/cma.j.issn.1673-9752.2019.08.001.

    Professional Committee of Hepatobiliary Hemangioma, Chinese Branch of the International Hepatobiliary and Pancreatic Association. Multidisciplinary expert consensus on the diagnosis and treatment of hepatic hemangioma (2019 edition)[J]. Chin J Dig Surg, 2019, 18(8): 705-710. DOI: 10.3760/cma.j.issn.1673-9752.2019.08.001.
    [3] TELLI TA, OKTEN IN, TUYLU TB, et al. VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: a case series with review of the literature[J]. Curr Probl Cancer, 2020, 44(5): 100568. DOI: 10.1016/j.currproblcancer.2020.100568.
    [4] SAKAMOTO Y, KOKUDO N, WATADANI T, et al. Proposal of size-based surgical indication criteria for liver hemangioma based on a nationwide survey in Japan[J]. J Hepatobiliary Pancreat Sci, 2017, 24(7): 417-425. DOI: 10.1002/jhbp.464.
    [5] EGHLIMI H, ARASTEH P, AZADE N. Orthotopic liver transplantation for management of a giant liver hemangioma: a case report and review of literature[J]. BMC Surg, 2020, 20(1): 142. DOI: 10.1186/s12893-020-00801-z.
    [6] 王连江, 张雅敏, 邓永林, 等. 肝移植治疗肝脏良性肿瘤六例临床分析[J]. 中华医学杂志, 2016, 96(26): 2091-2093. DOI: 10.3760/cma.j.issn.0376-2491.2016.26.011.

    WANG LJ, ZHANG YM, DENG YL, et al. Liver transplantation for benign liver tumor: six cases report and literature review[J]. Natl Med J China, 2016, 96(26): 2091-2093. DOI: 10.3760/cma.j.issn.0376-2491.2016.26.011.
    [7] LI T, KLAR MM, ALAWAD M, et al. Hepatic sclerosing hemangioma mimicking malignancy: a case and literature review[J]. Am J Med Case Rep, 2021, 9(3): 144-146. DOI: 10.12691/ajmcr-9-3-2.
    [8] UNAL E, FRANCIS F, AQUINO A, et al. Liver transplant for mixed capillary-cavernous hemangioma masquerading as hepatocellular carcinoma in a patient with hepatocellular carcinoma[J]. Exp Clin Transplant, 2011, 9(5): 344-348.
    [9] SOOD D, MOHAN N, SINGH A, et al. Living donor liver transplantation for giant cavernous hemangioma of liver in a child[J]. Pediatr Transplant, 2011, 15(7): E135-E138. DOI: 10.1111/j.1399-3046.2010.01320.x.
    [10] WANG Y, ZHOU Y, MIAO L. Pulmonary capillary hemangioma-like pulmonary artery hypertension associated with interferon-alpha therapy[J]. Am J Ther, 2020, 27(5): e511-e514. DOI: 10.1097/MJT.0000000000001141.
    [11] JI Y, CHEN S, YANG K, et al. Kaposiform hemangioendothelioma: current knowledge and future perspectives[J]. Orphanet J Rare Dis, 2020, 15(1): 39. DOI: 10.1186/s13023-020-1320-1.
    [12] VAGEFI PA, KLEIN I, GELB B, et al. Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review[J]. J Gastrointest Surg, 2011, 15(1): 209-214. DOI: 10.1007/s11605-010-1248-1.
    [13] 叶伯根, 朱红飞, 殷鹏, 等. 肝移植治疗肝脏巨大血管瘤和多囊肝三例临床分析[J/CD]. 中华移植杂志(电子版), 2020, 14(4): 241-244. DOI: 10.3877/cma.j.issn.1674-3903.2020.04.010.

    YE BG, ZHU HF, YIN P, et al. Liver transplantation for liver giant haemangioma and polycystic liver disease[J/CD]. Chin J Transplant (Electr Edit), 2020, 14(4): 241-244. DOI: 10.3877/cma.j.issn.1674-3903.2020.04.010.
    [14] KLOMPMAKER IJ, SLOOF MJ, VAN DER MEER J, et al. Orthotopic liver transplantation in a patient with a giant cavernous hemangioma of the liver and Kasabach-Merritt syndrome[J]. Transplantation, 1989, 48(1): 149-151. DOI: 10.1097/00007890-198907000-00035.
    [15] MORA A, CORTÉS C, ROIGÉ J, et al. Orthotopic liver transplant for giant cavernous hemangioma and Kasabach-Merritt syndrome[J]. Rev Esp Anestesiol Reanim, 1995, 42(2): 71-74.
    [16] TEPETES K, SELBY R, WEBB M, et al. Orthotopic liver transplantation for benign hepatic neoplasms[J]. Arch Surg, 1995, 130(2): 153-156. DOI: 10.1001/archsurg.1995.01430020043005.
    [17] BROUWERS MA, PEETERS PM, DE JONG KP, et al. Surgical treatment of giant haemangioma of the liver[J]. Br J Surg, 1997, 84(3): 314-316.
    [18] CHUI AK, VASS J, MCCAUGHAN GW, et al. Giant cavernous haemangioma: a rare indication for liver transplantation[J]. Aust N Z J Surg, 1996, 66(2): 122-124. DOI: 10.1111/j.1445-2197.1996.tb01132.x.
    [19] LONGEVILLE JH, DE LA HALL P, DOLAN P, et al. Treatment of a giant haemangioma of the liver with Kasabach-Merritt syndrome by orthotopic liver transplant a case report[J]. HPB Surg, 1997, 10(3): 159-162. DOI: 10.1155/1997/10136.
    [20] RUSSO MW, JOHNSON MW, FAIR JH, et al. Orthotopic liver transplantation for giant hepatic hemangioma[J]. Am J Gastroenterol, 1997, 92(10): 1940-1941.
    [21] KUMASHIRO Y, KASAHARA M, NOMOTO K, et al. Living donor liver transplantation for giant hepatic hemangioma with Kasabach-Merritt syndrome with a posterior segment graft[J]. Liver Transpl, 2002, 8(8): 721-724. DOI: 10.1053/jlts.2002.33689.
    [22] FERRAZ AA, SETTE MJ, MAIA M, et al. Liver transplant for the treatment of giant hepatic hemangioma[J]. Liver Transpl, 2004, 10(11): 1436-1437. DOI: 10.1002/lt.20250.
    [23] MEGURO M, SOEJIMA Y, TAKETOMI A, et al. Living donor liver transplantation in a patient with giant hepatic hemangioma complicated by Kasabach-Merritt syndrome: report of a case[J]. Surg Today, 2008, 38(5): 463-468. DOI: 10.1007/s00595-007-3623-4.
    [24] ZHONG L, MEN TY, YANG GD, et al. Case report: living donor liver transplantation for giant hepatic hemangioma using a right lobe graft without the middle hepatic vein[J]. World J Surg Oncol, 2014, 12: 83. DOI: 10.1186/1477-7819-12-83.
    [25] LANGE UG, BUCHER JN, SCHOENBERG MB, et al. Orthotopic liver transplantation for giant liver haemangioma: a case report[J]. World J Transplant, 2015, 5(4): 354-359. DOI: 10.5500/wjt.v5.i4.354.
    [26] LEE JH, YOON CJ, KIM YH, et al. Living-donor liver transplantation for giant hepatic hemangioma with diffuse hemangiomatosis in an adult: a case report[J]. Clin Mol Hepatol, 2018, 24(2): 163-168. DOI: 10.3350/cmh.2017.0002.
    [27] MASYUK TV, MASYUK AI, LARUSSO NF. Polycystic liver disease: advances in understanding and treatment[J]. Annu Rev Pathol, 2022, 17: 251-269. DOI: 10.1146/annurev-pathol-042320-121247.
    [28] BARTEN TRM, BERNTS LHP, DRENTH JPH, et al. New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney disease[J]. Expert Opin Ther Targets, 2020, 24(6): 589-599. DOI: 10.1080/14728222.2020.1751818.
    [29] ZHANG ZY, WANG ZM, HUANG Y. Polycystic liver disease: classification, diagnosis, treatment process, and clinical management[J]. World J Hepatol, 2020, 12(3): 72-83. DOI: 10.4254/wjh.v12.i3.72.
    [30] DOSHI SD, BITTERMANN T, SCHIANO TD, et al. Waitlisted candidates with polycystic liver disease are more likely to be transplanted than those with chronic liver failure[J]. Transplantation, 2017, 101(8): 1838-1844. DOI: 10.1097/TP.0000000000001711.
    [31] DRENTH JP, CHRISPIJN M, NAGORNEY DM, et al. Medical and surgical treatment options for polycystic liver disease[J]. Hepatology, 2010, 52(6): 2223-2230. DOI: 10.1002/hep.24036.
    [32] RODRÍGUEZ-AGUILAR EF, SASTRE L, COLMENERO J, et al. Liver and kidney transplantation in polycystic liver and kidney disease[J]. Gastroenterol Hepatol, 2021, 44(8): 552-558. DOI: 10.1016/j.gastrohep.2020.12.004.
    [33] VAN KEIMPEMA L, NEVENS F, ADAM R, et al. Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study[J]. Transpl Int, 2011, 24(12): 1239-1245. DOI: 10.1111/j.1432-2277.2011.01360.x.
    [34] DING F, TANG H, ZHAO H, et al. Long-term results of liver transplantation for polycystic liver disease: single-center experience in China[J]. Exp Ther Med, 2019, 17(5): 4183-4189. DOI: 10.3892/etm.2019.7449.
    [35] COQUILLARD C, BERGER J, DAILY M, et al. Combined liver-kidney transplantation for polycystic liver and kidney disease: analysis from the United Network for Organ Sharing dataset[J]. Liver Int, 2016, 36(7): 1018-1025. DOI: 10.1111/liv.13041.
    [36] ALSAGER M, NEONG SF, GANDHI R, et al. Liver transplantation in adult polycystic liver disease: the Ontario experience[J]. BMC Gastroenterol, 2021, 21(1): 115. DOI: 10.1186/s12876-021-01703-x.
    [37] MOORS G, POELS H, VANDECAVEYE V, et al. Regression of multiple hepatocellular adenomas after cessation of oral contraceptive pills: a case report and review of the current literature[J]. Acta Gastroenterol Belg, 2021, 84(3): 505-508. DOI: 10.51821/84.3.017.
    [38] OUDMAIJER CAJ, BERK KA, VAN DER LOUW EJTM, et al. KETOgenic diet therapy in patients with HEPatocellular adenoma: study protocol of a matched interventional cohort study[J]. BMJ Open, 2022, 12(2): e053559. DOI: 10.1136/bmjopen-2021-053559.
    [39] KRAUSE K, TANABE KK. A shifting paradigm in diagnosis and management of hepatic adenoma[J]. Ann Surg Oncol, 2020, 27(9): 3330-3338. DOI: 10.1245/s10434-020-08580-w.
    [40] ZHENG J, SADOT E, VIGIDAL JA, et al. Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing[J]. PLoS One, 2018, 13(7): e0200776. DOI: 10.1371/journal.pone.0200776.
    [41] JULIEN C, LE BAIL B, CHICHE L, et al. Malignant transformation of hepatocellular adenoma[J]. JHEP Rep, 2022, 4(3): 100430. DOI: 10.1016/j.jhepr.2022.100430.
    [42] HUANG WC, LIAU JY, JENG YM, et al. Hepatocellular adenoma in Taiwan: distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype[J]. J Gastroenterol Hepatol, 2020, 35(4): 680-688. DOI: 10.1111/jgh.14903.
    [43] FONSECA EA, FEIER F, VINCENZI R, et al. Living donor liver transplantation as a backup procedure: treatment strategy for hepatocellular adenomas requiring complex resections[J]. Case Rep Surg, 2022: 1015061. DOI: 10.1155/2022/1015061.
    [44] SANTAMBROGIO R, MARCONI AM, CERETTI AP, et al. Liver transplantation for spontaneous intrapartum rupture of a hepatic adenoma[J]. Obstet Gynecol, 2009, 113(2 Pt 2): 508-510. DOI: 10.1097/AOG.0b013e318187ff42.
    [45] MARTINS-FILHO SN, PUTRA J. Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review[J]. Hepat Oncol, 2020, 7(2): HEP19. DOI: 10.2217/hep-2020-0002.
    [46] LI J, CAI JZ, GUO QJ, et al. Liver transplantation for a giant mesenchymal hamartoma of the liver in an adult: case report and review of the literature[J]. World J Gastroenterol, 2015, 21(20): 6409-6416. DOI: 10.3748/wjg.v21.i20.6409.
    [47] HERNÁNDEZ JC, ALFONSO C, GONZÁLEZ L, et al. Solid mesenchymal hamartoma in an adult: a case report[J]. J Clin Pathol, 2006, 59(5): 542-545. DOI: 10.1136/jcp.2004.024398.
    [48] PAN ET, YOELI D, KUEHT ML, et al. Liver transplantation as definitive treatment of an unresectable mesenchymal hamartoma in a child with Beckwith-Wiedemann syndrome[J]. J Surg Case Rep, 2017(8): rjx167. DOI: 10.1093/jscr/rjx167.
    [49] WANG KH, KUPA J, DUFFY KA, et al. Diagnosis and management of Beckwith-Wiedemann syndrome[J]. Front Pediatr, 2020, 7: 562. DOI: 10.3389/fped.2019.00562.
    [50] KLOMPENHOUWER AJ, VERVER D, JANKI S, et al. Management of hepatic angiomyolipoma: a systematic review[J]. Liver Int, 2017, 37(9): 1272-1280. DOI: 10.1111/liv.13381.
    [51] YANG G, HWANG S, AHN CS, et al. Clinicopathological correlation and post-resection outcomes of hepatic angiomyolipoma[J]. Ann Hepatobiliary Pancreat Surg, 2021, 25(2): 215-220. DOI: 10.14701/ahbps.2021.25.2.215.
    [52] KLOMPENHOUWER AJ, DWARKASING RS, DOUKAS M, et al. Hepatic angiomyolipoma: an international multicenter analysis on diagnosis, management and outcome[J]. HPB (Oxford), 2020, 22(4): 622-629. DOI: 10.1016/j.hpb.2019.09.004.
    [53] STEINBORN JK, RAWITZER J, GALLINAT A, et al. Angiomyolipoma of the liver-a case report and review of the literature[J]. Pathologe, 2020, 41(6): 643-648. DOI: 10.1007/s00292-020-00834-4.
    [54] DUMORTIER J, GUILLAUD O, WALTER T, et al. Liver transplantation for multiple angiomyolipomas complicating tuberous sclerosis complex[J]. Gastroenterol Clin Biol, 2010, 34(8/9): 494-498. DOI: 10.1016/j.gcb.2010.06.005.
    [55] WANG WT, LI ZQ, ZHANG GH, et al. Liver transplantation for recurrent posthepatectomy malignant hepatic angiomyolipoma: a case report[J]. World J Gastroenterol, 2015, 21(12): 3755-3758. DOI: 10.3748/wjg.v21.i12.3755.
    [56] BRAHMBHATT M, PRENNER S, BITTERMANN T. Liver transplantation for hepatic epithelioid hemangioendothelioma is facilitated by exception points with acceptable long-term outcomes[J]. Transplantation, 2020, 104(6): 1187-1192. DOI: 10.1097/TP.0000000000002982.
    [57] LAI Q, FEYS E, KARAM V, et al. Hepatic epithelioid hemangioendothelioma and adult liver transplantation: proposal for a prognostic score based on the analysis of the ELTR-ELITA Registry[J]. Transplantation, 2017, 101(3): 555-564. DOI: 10.1097/TP.0000000000001603.
  • 加载中
图(1)
计量
  • 文章访问数:  45
  • HTML全文浏览量:  22
  • PDF下载量:  5
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-05-26
  • 网络出版日期:  2022-11-14
  • 刊出日期:  2022-11-15

目录

    /

    返回文章
    返回